Who owns IDEAYA Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IDYA from SEC Form 13F filings across 281 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 281 institutions disclosed 100.7M shares of IDEAYA Biosciences, Inc. worth $3.87B — about 97.8% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
281
13F holders
$3.87B
value, 2026 filers
97.8%
of shares outstanding (100.7M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IDYA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 14.5M | $556.0M | 0.0% | 14.1% | +2.6% |
| 2 | BlackRock, Inc. | 9.5M | $366.9M | 0.0% | 9.3% | +7.4% |
| 3 | Janus Henderson Group Ltd.NEW | 8.6M | $331.4M | 0.1% | 8.4% | new |
| 4 | Capital Research Global Investors | 5.3M | $205.2M | 0.0% | 5.2% | -0.1% |
| 5 | BAKER BROS. ADVISORS LP | 5.0M | $192.5M | 0.9% | 4.9% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3M | $165.7M | 0.0% | 4.2% | +4.3% |
| 7 | STATE STREET CORP | 3.9M | $150.9M | 0.0% | 3.8% | -13.7% |
| 8 | Logos Global Management LP | 2.9M | $109.5M | 5.9% | 2.8% | -5.0% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.7M | $104.3M | 0.1% | 2.6% | 0.0% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $97.8M | 0.0% | 2.5% | +4.9% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.1M | $82.0M | 0.0% | 2.1% | -3.3% |
| 12 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2.0M | $77.0M | 1.2% | 1.9% | -26.2% |
| 13 | MORGAN STANLEY | 1.9M | $73.9M | 0.0% | 1.9% | -0.5% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 1.7M | $66.3M | 0.0% | 1.7% | +3.9% |
| 15 | ALLIANCEBERNSTEIN L.P. | 1.5M | $58.9M | 0.0% | 1.5% | -5.8% |
| 16 | Fiera Capital Corp | 1.5M | $56.7M | 0.2% | 1.4% | +2.0% |
| 17 | GOLDMAN SACHS GROUP INC | 1.5M | $55.9M | 0.0% | 1.4% | +18.1% |
| 18 | FEDERATED HERMES, INC. | 1.4M | $54.9M | 0.1% | 1.4% | -0.3% |
| 19 | GSK plc | 1.3M | $51.2M | 10.3% | 1.3% | 0.0% |
| 20 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | $51.1M | 0.0% | 1.3% | +4.8% |
| 21 | Candriam S.C.A. | 1.1M | $42.8M | 0.2% | 1.1% | +1.7% |
| 22 | BANK OF AMERICA CORP /DE/ | 1.0M | $39.2M | 0.0% | 1% | -0.6% |
| 23 | Sofinnova Investments, Inc. | 946,340 | $36.4M | 1.6% | 0.9% | +2.3% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 882,407 | $33.9M | 0.0% | 0.9% | +7.4% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 846,987 | $32.5M | 0.0% | 0.8% | +12.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.